ASN QBank Pearls - Potassium, Acid Base, Tubulointerstitial Disorders, and Nephrolithiasis Flashcards
(139 cards)
- low PRA (plasma renin activity)
- high PAC (plasma aldosterone concentration)
- aldosterone synthesis independent of renin levels
primary aldosteronism
- low PRA
- high PAC
- high urine free cortisol/cortisone ratio
- high ACTH
- AD
- cortisol-producing zona fasciculata defect d/t promoter fusion causing ACTH dependent activation of aldosterone synthase on cortisol precursors
glucocorticoid-remediable aldosteronism
- low PRA
- high PAC
- mass > 5 cm
adrenal Ca
- high PRA
- high PAC
- atherosclerosis
- hypoxia-induced
renovascular HTN
- high PRA
- high PAC
- unregulated synthesis
renin-secreting tumor
- low/normal PRA
- low/normal PAC
- high cortisol
- high urine free cortisol/cortisone ratio
- excess cortisol production
Cushing disease
- low/normal PRA
- low/normal PAC
- high cortisol
- high urine free cortisol/cortisone ratio
- mutation of 11-BHSD2
syndrome of apparent mineralocorticoid excess (SAME)
syndrome of apparent mineralocorticoid excess (SAME) causes
- can be inherited
- can be acquired;
- black European licorice (glycyrrhizic acid)
- itraconazole
- ectopic ACTH
- grapefruit
- low/normal PRA
- low/normal PAC
- low/normal cortisol
- low/normal urine free cortisol/cortisone ratio
- hypokalemia
- AD
- ENaC gain of function mutation
Liddle syndrome
- low/normal PRA
- low/normal PAC
- low/normal cortisol
- low/normal urine free cortisol/cortisone ratio
- worse w/ pregnancy and spironolactone
mineralocorticoid receptor gain of function mutation (Geller’s syndrome)
- young female with HTN and hypokalemia
- family h/o early onset HTN and hemorrhagic stroke
- urinary K+ wasting
- increased urinary excretion of aldosterone and 18-OH cortisol during salt loading
glucocorticoid remediable aldosteronism
treatment of glucocorticoid remediable aldosteronism
spironolactone and dexamethasone
- severe HTN with metabolic alkalosis and hypokalemia
- young women during the second and third trimester of pregnancy
mineralocorticoid corticoid receptor mutation (Geller’s syndrome)
MR 810 mutation is activated by what medication, thereby worsening hypertension and hypokalemia
spironolactone
treatment of mineralocorticoid corticoid receptor mutation (Geller’s syndrome)
- often requires delivery
- subsequent management includes avoidance of spironolactone
hyperemic optic disks and putamen swelling are suggestive of
methanol intoxication
changes in mentation as a result of methanol are present w/i the first 6-24 hours but can be the only abnormality for as long as 72-96 hours if patients have also ingested, what?
ethanol (competes for ADH)
methanol metabolite
formic acid
- changes in mentation
- HAGMA
- large osmolal gap
- less likely to have cerebral edema
ethylene glycol toxicity
- ketoacidosis (typically after patient stops drinking)
- usually small osmolal gap
ethanol toxicity
solvent used for lorazepam, diazepam, and phenobarbital
propylene glycol
- large osmolal gap
- HAGMA
- AKI
- can progress to multisystem organ failure, if severe
- usually a/w dosages above the recommended range of 0.1 mg/kg/hr and/or renal impairment
propylene glycol toxicity
- HTN at young age
- CVA at young age
- low aldosterone level
- hypokalemia
- metabolic alkalosis
Liddle’s syndrome
- hypokalemia
- normo- or hypotension
Bartter’s or Gitelman’s syndromes